A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine).
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Corticosteroids|DRUG: Placebo|DRUG: capecitabine [Xeloda]|DRUG: dexpantenol [Bepantol]
Sponsor: Hoffmann-La Roche